4//SEC Filing
Namouni Fouad 4
Accession 0001415889-25-007402
CIK 0001597264other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:13 PM ET
Size
5.0 KB
Accession
0001415889-25-007402
Insider Transaction Report
Form 4
Namouni Fouad
PRESIDENT, R & D
Transactions
- Sale
Common Stock
2025-03-05$88.80/sh−6,489$576,223→ 75,781 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001815851
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:13 PM ET
- Size
- 5.0 KB